Table 1.
Agent | Dose | SCE | M1 | M2 | M3 | AGT | MI | ||
mg/kg |
|
% | % | % |
|
|
|||
MO | — | 1.88 ± 0.12 | 38 | 48 | 14 | 12.15 ± 0.23 | 5.73 ± 0.34 | ||
BS | 200 | 2.12 ± 0.28 | 32 | 53 | 15 | 12.14 ± 0.17 | 5.66 ± 0.29 | ||
BS | 400 | 1.54 ± 0.21 | 36 | 50 | 14 | 12.45 ± 0.12 | 5.70 ± 0.18 | ||
BS | 600 | 1.34 ± 0.24 | 34 | 55 | 11 | 12.55 ± 0.10 | 5.58 ± 0.33 | ||
BS | 1000 | 1.0 ± 0.34 | 33 | 52 | 15 | 12.35 ± 0.18 | 6.03 ± 0.22 | ||
DR | 10 | *16.83 ± 0.42 | 33 | 58 | 9 | 12.37 ± 0.31 | 6.43 ± 0.41 | ||
DW | — | 2.51 ± 0.12 | 34 | 51 | 15 | 12.45 ± 0.23 | 5.94 ± 0.19 | ||
PT | 100 | 1.15 ± 0.16 | 35 | 51 | 14 | 12.36 ± 0.14 | 5.97 ± 0.26 | ||
PT | 200 | 2.03± 0.27 | 37 | 50 | 13 | 12.46 ± 0.21 | 5.80 ± 0.38 | ||
PT | 300 | 1.08 ± 0.57 | 34 | 51 | 15 | 12.25 ± 0.33 | 6.70 ± 0.18 | ||
PT | 600 | 1.44 ± 0.22 | 34 | 49 | 17 | 12.63 ± 0.16 | 7.13 ± 0.17 | ||
DR | 10 | *14.06 ± 0.68 | 39 | 50 | 11 | 12.47 ± 0.26 | 6.16 ± 0.68 |
*Statistically significant difference with respect to the result obtained in the negative control group. ANOVA and Student t tests, P ≤ .05.